These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20415821)

  • 1. Psoriasis and cardiovascular disease.
    Vena GA; Vestita M; Cassano N
    Dermatol Ther; 2010; 23(2):144-51. PubMed ID: 20415821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis: a skin disease associated with increased cardiovascular risk.
    González-Gay MA; González-Vela C; González-Juanatey C
    Actas Dermosifiliogr; 2012 Sep; 103(7):595-8. PubMed ID: 22465257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors.
    Gisondi P; Girolomoni G
    Semin Thromb Hemost; 2009 Apr; 35(3):313-24. PubMed ID: 19452407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and metabolic risk profile in German patients with moderate and severe psoriasis: a case control study.
    Warnecke C; Manousaridis I; Herr R; Terris DD; Goebeler M; Goerdt S; Peitsch WK
    Eur J Dermatol; 2011; 21(5):761-70. PubMed ID: 21737374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis.
    Kaye JA; Li L; Jick SS
    Br J Dermatol; 2008 Sep; 159(4):895-902. PubMed ID: 18616778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk and psoriasis: the role of biologic therapy.
    Puig L
    Actas Dermosifiliogr; 2012 Dec; 103(10):853-62. PubMed ID: 23157913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample.
    Schmitt J; Ford DE
    J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):885-92. PubMed ID: 20015170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increase of homocysteine in cardiovascular diseases in Hungary].
    Balogh E; Czuriga I; Bereczky Z; Boda K; Koszegi Z; Kónya C; Császár A; Muszbek L; Edes I; Ferdinandy P
    Orv Hetil; 2006 Sep; 147(35):1685-90. PubMed ID: 17051744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis, the liver, and the gastrointestinal tract.
    Gisondi P; Del Giglio M; Cozzi A; Girolomoni G
    Dermatol Ther; 2010; 23(2):155-9. PubMed ID: 20415823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis: cardiovascular risk factors and other disease comorbidities.
    Wu Y; Mills D; Bala M
    J Drugs Dermatol; 2008 Apr; 7(4):373-7. PubMed ID: 18459519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors.
    Olsen MH; Christensen MK; Hansen TW; Gustafsson F; Rasmussen S; Wachtell K; Borch-Johnsen K; Ibsen H; Jørgensen T; Hildebrandt P
    J Hypertens; 2006 Apr; 24(4):655-61. PubMed ID: 16531793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community.
    Menter A; Griffiths CE; Tebbey PW; Horn EJ; Sterry W;
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1371-7. PubMed ID: 20384692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic plaque psoriasis is associated with increased arterial stiffness.
    Gisondi P; Fantin F; Del Giglio M; Valbusa F; Marino F; Zamboni M; Girolomoni G
    Dermatology; 2009; 218(2):110-3. PubMed ID: 19060461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies.
    Driessen RJ; Boezeman JB; Van De Kerkhof PC; De Jong EM
    J Dermatolog Treat; 2009; 20(1):42-7. PubMed ID: 18649164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
    Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
    J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects.
    Holven KB; Aukrust P; Retterstol K; Hagve TA; Mørkrid L; Ose L; Nenseter MS
    Scand J Clin Lab Invest; 2006; 66(1):45-54. PubMed ID: 16464786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical cardiovascular disease in plaque psoriasis: association or causal link?
    Shaharyar S; Warraich H; McEvoy JW; Oni E; Ali SS; Karim A; Jamal O; Blaha MJ; Blumenthal RS; Fialkow J; Cury R; Budoff MJ; Agatston AA; Nasir K
    Atherosclerosis; 2014 Jan; 232(1):72-8. PubMed ID: 24401219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis and cardiovascular comorbidities with emphasis in Asia.
    Chu TW; Tsai TF
    G Ital Dermatol Venereol; 2012 Apr; 147(2):189-202. PubMed ID: 22481582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of the framingham risk score in patients with chronic psoriasis.
    Gisondi P; Farina S; Giordano MV; Girolomoni G
    Am J Cardiol; 2010 Dec; 106(12):1754-7. PubMed ID: 21055711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.